Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) mainly prescribed in the treatment of depression, anxiety disorders, bulimia nervosa, and premenstrual syndrome. Although SSRIs have been reported to potentially be associated with an increased risk of bleeding, fluoxetine-induced ecchymosis is rare, with few cases in the current literature. We report the case of a female patient who manifested lower-extremity ecchymosis related to fluoxetine use.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.